$-0.29
(Market cap
$655 Mln
Recently Viewed
Clear AllMarket cap
$655 Mln
Revenue (TTM)
$55 Mln
P/E Ratio
90.9
P/B Ratio
9
Div. Yield
0 %
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
$0 Mln
ROE
0.1 %
ROCE
-- %
Industry P/E
46.76
EV/EBITDA
61.1
Debt to Equity
0
Book Value
$--
EPS
$--
Face value
--
Shares outstanding
40,033,026
CFO
$-34.26 Mln
EBITDA
$-49.00 Mln
Net Profit
$-66.28 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
BrainsWay - ADR
| 232.5 | 22.8 | 155.9 | 606.6 | 244.3 | 48.5 | -- |
|
BSE Sensex
| -8.5 | 5.3 | -5.9 | -3.4 | 8.2 | 9.3 | 11.7 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
|---|---|---|---|---|---|---|
|
BrainsWay - ADR
| 101.7 | 45.1 | 162.3 | -67.9 | 2.1 | -22.7 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
BrainsWay - ADR
|
15.8 | 655.3 | 55.4 | 9.5 | 15.4 | 13.3 | 90.9 | 9.0 |
| 91.9 | 160,700.9 | 45,134.0 | 6,276.0 | 15.4 | 24.6 | 25.9 | 3.1 | |
| 56.2 | 97,626.9 | 20,615.0 | 3,553.0 | 10.0 | 30.4 | 27.5 | 4.0 | |
| 177.6 | 126,386.6 | 24,778.0 | 3,689.0 | 18.7 | 7.1 | 34.6 | 2.4 | |
| 451.0 | 170,784.4 | 10,582.1 | 2,979.1 | 22.4 | 17.2 | 58.5 | 9.7 | |
| 1.0 | 18.4 | 55.5 | -2.9 | -1.6 | -61.1 | -- | 269.8 | |
| 465.0 | 173,435.7 | 45,197.0 | 6,859.0 | 19.2 | 13.3 | 25.6 | 3.3 | |
| 66.0 | 213.9 | 37.5 | 10.9 | 27.3 | 9.1 | 19.5 | 1.8 | |
| 0.8 | 11.4 | 18.3 | -24.3 | -87.6 | -- | -- | 6.9 | |
| 293.4 | 21,629.5 | 3,220.4 | 542.7 | 15.3 | 18 | 41.3 | 7.3 |
BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, East Asia, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of... major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company serves doctors, hospitals, and medical centers in the field of psychiatry. The company was founded in 2003 and is headquartered in Jerusalem, Israel. Read more
Chief Executive Officer
Mr. Hadar Levy
Chief Executive Officer
Mr. Hadar Levy
Headquarters
Jerusalem
Website
Our rating system has guided millions of investors in the past 20 years.
The share price of BrainsWay Ltd - ADR is $15.81 (NASDAQ) as of 29-Apr-2026 13:28 EDT. BrainsWay Ltd - ADR has given a return of 244.26% in the last 3 years.
The P/E ratio of BrainsWay Ltd - ADR is 90.94 times as on 24-Apr-2026, a 94 premium to its peers’ median range of 46.76 times.
The P/B ratio of BrainsWay Ltd - ADR is 9.01 times as on 24-Apr-2026, a 178 premium to its peers’ median range of 3.24 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
49.44
|
5.20
|
|
2024
|
54.88
|
2.57
|
|
2023
|
-26.25
|
2.65
|
|
2022
|
-2.96
|
0.87
|
|
2021
|
-19.07
|
2.15
|
The 52-week high and low of BrainsWay Ltd - ADR are Rs 16.69 and Rs 2.15 as of 29-Apr-2026.
BrainsWay Ltd - ADR has a market capitalisation of $ 655 Mln as on 24-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in BrainsWay Ltd - ADR, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.